{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T16:52:32Z","timestamp":1760979152001},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.brainres.2003.09.035","type":"journal-article","created":{"date-parts":[[2003,11,8]],"date-time":"2003-11-08T12:12:47Z","timestamp":1068293567000},"page":"188-192","source":"Crossref","is-referenced-by-count":7,"title":["Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats"],"prefix":"10.1016","volume":"994","author":[{"given":"Ole A.","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Waage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente","family":"Finsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo A.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2003.09.035_BIB1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?","volume":"61","author":"Andreassen","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2003.09.035_BIB2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1476-5381.1996.tb15736.x","article-title":"Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats","volume":"119","author":"Andreassen","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2003.09.035_BIB3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0306-4522(98)00175-4","article-title":"The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing preproenkephalin messenger RNA in rats","volume":"88","author":"Andreassen","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2003.09.035_BIB4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s002130100767","article-title":"Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration","volume":"157","author":"Andreassen","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainres.2003.09.035_BIB5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1471-4159.1992.tb09368.x","article-title":"Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain","volume":"58","author":"Angulo","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2003.09.035_BIB6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-4886(92)90106-Z","volume":"117","author":"Auchus","year":"1992","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2003.09.035_BIB7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0893-133X(00)00086-5","article-title":"Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs","volume":"23","author":"Bauer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2003.09.035_BIB8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410330516","article-title":"Neuroleptic medications inhibit complex I of the electron transport chain","volume":"33","author":"Burkhardt","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2003.09.035_BIB9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1471-4159.1994.63020777.x","article-title":"Regulation of mu-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short- and long-term haloperidol administration","volume":"63","author":"Delfs","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2003.09.035_BIB10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/syn.890180303","article-title":"Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias","volume":"18","author":"Egan","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2003.09.035_BIB11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1176\/ajp.152.12.1730","article-title":"Tardive dyskinesia and substrates of energy metabolism in CSF","volume":"152","author":"Goff","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2003.09.035_BIB12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/309347a0","article-title":"Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis","volume":"309","author":"Gunne","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2003.09.035_BIB13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0006-8993(79)90618-8","article-title":"Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum","volume":"160","author":"Hong","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2003.09.035_BIB14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/schbul\/19.2.303","article-title":"Tardive dyskinesia","volume":"19","author":"Jeste","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainres.2003.09.035_BIB15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00445547","article-title":"Intranigral infusion of enkephalins elicits dyskinetic biting in rats","volume":"99","author":"Liminga","year":"1989","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainres.2003.09.035_BIB16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0306-4522(02)00127-6","article-title":"Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia","volume":"112","author":"McCormick","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2003.09.035_BIB17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-3223(93)90044-E","article-title":"Loss of striatal cholinergic neurons as a basis for tardive and l-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia","volume":"34","author":"Miller","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2003.09.035_BIB18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0925-4927(91)90007-D","article-title":"MRI abnormalities in tardive dyskinesia","volume":"40","author":"Mion","year":"1991","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2003.09.035_BIB19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/syn.890140302","article-title":"Depolarization inactivation of dopamine neurons: terminal release characteristics","volume":"14","author":"Moghaddam","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2003.09.035_BIB20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0140-6736(87)92987-4","article-title":"Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines","volume":"2","author":"Pall","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2003.09.035_BIB21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2003.09.035_BIB22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0006-8993(00)02017-5","article-title":"No changes in dopamine D1 receptor mRNA expressing neurons in the dorsal striatum of rats with oral movements induced by long-term haloperidol treatment","volume":"859","author":"Petersen","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2003.09.035_BIB23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2003.09.035_BIB24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s002130000570","article-title":"Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats","volume":"153","author":"Sakai","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainres.2003.09.035_BIB25","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","article-title":"Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia","volume":"155","author":"Tsai","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2003.09.035_BIB26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-9861(19960617)370:1<11::AID-CNE2>3.0.CO;2-O","article-title":"Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method","volume":"370","author":"West","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2003.09.035_BIB27","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1523\/JNEUROSCI.14-07-04159.1994","article-title":"Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations","volume":"14","author":"Yamamoto","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2003.09.035_BIB28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0197-0186(95)00070-4","article-title":"NMDA receptor antagonist MK-801 down-regulates rat striatal proenkephalin and protachykinin mRNAs","volume":"28","author":"Zhang","year":"1996","journal-title":"Neurochem. Int."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899303037533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899303037533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T17:40:24Z","timestamp":1585244424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899303037533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0006899303037533"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2003.09.035","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}